Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Omaha, Nebraska 68131


The purpose of this study is to test whether once-weekly prozac therapy leads to reduction in depression in patients requiring kidney dialysis.

Study summary:

Once-weekly Prozac is a psychiatric medicine, approved by the FDA for the use in treatment of psychiatric disorders. This study will test whether once-weekly Prozac leads to reduced symptoms of depression. Patients requiring dialysis often report symptoms of depression either due to the presence of major depression, a relatively common psychiatric disorder, or due to depression secondary to kidney failure.


Inclusion Criteria: - Diagnosis of chronic renal failure and end stage renal disease - Ongoing need for regular dialysis treatment - Diagnosis of depression based on DSMIV - Age tween 19-65 years Exclusion Criteria: - Inability to provide informed consent - Medically or psychiatrically unstable, as defined by requiring inpatient treatment - Pregnancy, nursing or refusal to use a reliable method of birth control in women - Patients with known allergy to fluoxetine, or previous treatment failure of fluoxetine



Primary Contact:

Principal Investigator
Syed P Sattar, MD
Creighton University Department of Psychiatry

Backup Contact:


Location Contact:

Omaha, Nebraska 68131
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.